Yu‐Kang Chang
Papers
2
Total Citations
7
H-Index
2
About
Yu-Kang Chang is a urologic surgeon and researcher whose work centers on robotic-assisted surgery for urologic cancers, with a particular focus on renal and prostate malignancies. His most impactful contribution comes from a landmark single-surgeon study on robotic partial nephrectomy for renal tumors, which examined the "pentafecta" outcomes—a composite measure of oncologic control, functional preservation, and surgical quality—in patients treated over a 13-year period in Taiwan. This work, which has garnered 5 citations, provides valuable real-world evidence on the efficacy of robot-assisted nephron-sparing surgery. Chang has also investigated early dutasteride monotherapy for patients with detectable PSA levels following robot-assisted radical prostatectomy, contributing to the management of biochemical recurrence. His research addresses critical questions in urologic oncology, balancing cancer control with quality of life. By focusing on long-term, single-surgeon outcomes, Chang offers insights into surgical learning curves and best practices that inform both clinical decision-making and training. His work continues to shape the evidence base for robotic urologic surgery in Asian populations.
Research Focus
Key Achievements
Top Papers
- 1
- 2